Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery. It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Lexington, Kentucky.
Frequently asked questions
What sector does Cardiff Lexington Corp (CDIX) operate in?
Cardiff Lexington Corp belongs to the Financials sector and operates in the Medical Care Facilities industry.
What is Cardiff Lexington Corp (CDIX) current stock price?
As of the latest data, Cardiff Lexington Corp stock price is $0.02, with a previous close of $0.03. Cardiff Lexington Corp lost -$0.01 in the last trading session, representing a -28% loss.
What is Cardiff Lexington Corp (CDIX) current market capitalization?
Cardiff Lexington Corp market cap is approximately 281.47 thousand.
What is Cardiff Lexington Corp (CDIX) Earnings Per Share (EPS)?
The trailing EPS is -$1.00.
What is Cardiff Lexington Corp (CDIX) EBITDA?
Cardiff Lexington Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -544.39 thousand.
Does Cardiff Lexington Corp (CDIX) pay dividends?
No. Cardiff Lexington Corp does not pay a dividend.
What is Cardiff Lexington Corp (CDIX) beta (volatility) score?
Cardiff Lexington Corp has a beta of 1.973, suggesting it is more volatile than the market.
